Intrapericardial Ibutilide Administration Fails to Terminate Pacing-Induced Sustained Atrial Fibrillation in Dogs

[21] Nakamura F(1998)Altered response to ibu-tilide in a heart failure model Am Heart J 135 1048-1054

[22] Waltenberger J.(1992)Suppression of inducible ventricular tachycardia by ibutilide in patients with coronary artery disease. Ibutilide investigators J Cardiovasc Pharmacol 19 256-263

[23] Ware JA(1999)Effects of ibutilide on spontaneous and induced ventric-ular arrhythmias in 24-hour canine myocardial infarction: A comparative study with sotalol and encainide J Cardiovasc Pharmacol 34 237-247

[24] Simons M.(1997)Electropharma-cologic characteristics of ventricular proarrhythmia induced by ibutilide Circu-lation 96 4298-4306

[25] Willerson JT(1996)Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Electrophysio-logical determinants of enhanced conversion efficacy Circulation 94 1613-1621

[26] Igo SR(2001)Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation J Cardiovasc Electrophysiol 12 330-336

[27] Yao SK(1994)Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs, when procainamide and ibutilide are delivered into the right atrium versus intravenously J Cardiovasc Phar-macol 24 826-840

[28] Ober JC(2000)Epicardial administration of ibutilide from polyurethane matrices: Effects on defibrillation thresh-old and electrophysiologic parameters Circulation 102 104-112

[29] Macris MP(2003)Contrasting efficacy of dofetilide in differing experimental models of atrial fibril-lation Circulation 107 1440-1446

[30] Ferguson JJ.(2002)Effects of antiarrhythmic drugs on fibrillation in the remod-eled atrium. Insights into the mechanism of the superior efficacy of amiodarone JAmColl Cardiol 40 2150-2155

[21] Nakamura F(1998)Altered response to ibu-tilide in a heart failure model Am Heart J 135 1048-1054

[22] Waltenberger J.(1992)Suppression of inducible ventricular tachycardia by ibutilide in patients with coronary artery disease. Ibutilide investigators J Cardiovasc Pharmacol 19 256-263

[23] Ware JA(1999)Effects of ibutilide on spontaneous and induced ventric-ular arrhythmias in 24-hour canine myocardial infarction: A comparative study with sotalol and encainide J Cardiovasc Pharmacol 34 237-247

[24] Simons M.(1997)Electropharma-cologic characteristics of ventricular proarrhythmia induced by ibutilide Circu-lation 96 4298-4306

[25] Willerson JT(1996)Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Electrophysio-logical determinants of enhanced conversion efficacy Circulation 94 1613-1621

[26] Igo SR(2001)Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation J Cardiovasc Electrophysiol 12 330-336

[27] Yao SK(1994)Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs, when procainamide and ibutilide are delivered into the right atrium versus intravenously J Cardiovasc Phar-macol 24 826-840

[28] Ober JC(2000)Epicardial administration of ibutilide from polyurethane matrices: Effects on defibrillation thresh-old and electrophysiologic parameters Circulation 102 104-112

[29] Macris MP(2003)Contrasting efficacy of dofetilide in differing experimental models of atrial fibril-lation Circulation 107 1440-1446

[30] Ferguson JJ.(2002)Effects of antiarrhythmic drugs on fibrillation in the remod-eled atrium. Insights into the mechanism of the superior efficacy of amiodarone JAmColl Cardiol 40 2150-2155